Planet 13 Holdings (PLNH) EBIT Margin Growth (3y) (2024 - 2026)

Planet 13 Holdings (PLNH) EBIT Margin Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,673.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -37.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5,395.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,442.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -1,299.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 5,091.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 5,193.00
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn -914.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -914.00
Dec 31, 2025 13,808.00
Sep 30, 2025 -16,011.00
Jun 30, 2025 -1,902.00
Mar 31, 2025 -915.00
Dec 31, 2024 -9,082.00
Sep 30, 2024 1,069.00
Jun 30, 2024 61,924.00
Mar 31, 2024 -3,192.00